Replies to post #156941 on Biotech Values

[DewDiligence]

I guess MYL picked up what PFE terminated a similar deal with Biocon last year. Refresh my memory, was ever given a reason by anyone?

No official reason was ever given, to my knowledge. In #msg-73195053, I speculated that PFE was concerned MYL would expand its collaboration with Biocon to include insulin (which turned out to be exactly what happened).